Neuropharmacology of attention

Eur J Pharmacol. 2018 Sep 15:835:162-168. doi: 10.1016/j.ejphar.2018.08.008. Epub 2018 Aug 6.

Abstract

Early philosophers and psychologists defined and began to describe attention. Beginning in the 1950's, numerous models of attention were developed. This corresponded with an increased understanding of pharmacological approaches to manipulate neurotransmitter systems. The present review focuses on the knowledge that has been gained about these neurotransmitter systems with respect to attentional processing, with emphasis on the functions mediated within the medial prefrontal cortex. Additionally, the use of pharmacotherapies to treat psychiatric conditions characterized by attentional dysfunction are discussed. Future directions include developing a more comprehensive understanding of the neural mechanisms underlying attentional processing and novel pharmacotherapeutic targets for conditions characterized by aberrant attentional processing.

Keywords: Attention; Neurotransmitter; Prefrontal cortex; Vigilance.

Publication types

  • Review

MeSH terms

  • Animals
  • Attention / drug effects*
  • Humans
  • Neuropharmacology / methods*